In patients with Alzheimer’s disease, accumulation of amyloid-β induced elevation of β-amyloid precursor protein expression is mediated by cytosolic phospholipase A2-α, prostaglandin E2 release, and cAMP response element-binding protein activation via the protein kinase A pathway (76). The gene discussed is PLB1; the disease is Alzheimer disease.